HV2 - Module 6

1234567891011121314151617
Across
  1. 4. - Step 3 of COPD treatment. Decreases inflammation. Eg: Beclomethasone.
  2. 6. - Step 2 of COPD treatment. Long acing muscarinic ---. LAMA. Eg: Oldaterol.
  3. 9. - Step 1 of COPD treatment. Short-acting relievers. Short-acting --- agonists. SABA. Bronchodilators. Eg: Salbutamol.
  4. 11. - A --- x-ray is a COPD diagnostic test. Long lung fields and flattening of the diaphragm due to hyperinflation and evidence of pulmonary infection if present.
  5. 13. - Step 2 of COPD treatment. Long acting ---. LABA. Eg: Tiotropium.
  6. 14. - Hypersecretion of mucus and chronic productive cough for at least 3 months of the year for at least 2 consecutive years.
  7. 16. - Inhaled cortico --- are a pharmacological treatment for COPD. Eg: Beclomethasone.
  8. 17. - Examining serum 1 --- levels is a COPD diagnostic test. To screen for deficiency, in person with a family history, those with an early onset, women, and non-smokers. Normal is 90-200mg/dL.
Down
  1. 1. - --- function testing is a COPD diagnostic test. Tested by the increased total lung capacity and residual volume.
  2. 2. - Abnormal permanent enlargement of gas exchange airways accompanied by destruction of alveolar walls.
  3. 3. - Pulse --- is a COPD diagnostic test. Marked airway obstruction and hypoxaemia. Monitor SpO2 less than 95%.
  4. 5. - Selective Beta 2 --- are a pharmacological treatment for COPD. Eg: Salbutamol.
  5. 7. - Step 1 of COPD treatment. Short-acting relievers. Short-acting --- agonists. SAMA. Mucus expulsion. Eg: Ipratropium.
  6. 8. - --- perfusion scanning is a COPD diagnostic test. Lung tissue is ventilated by not perfused (dead space) or perfused but inadequately ventilated, which is called physiological shunting.
  7. 10. - --- with white blood cells is a COPD diagnostic test. Increased WBC and high percentage of immature WBCs lead to bacterial infection.
  8. 12. - --- carbon dioxide is a COPD diagnostic test. Normal ETCO2 is 35-45mmHg; it is elevated when ventilation is inadequate and decreased when pulmonary perfusion is impaired.
  9. 15. - A progressive chronic disease characterised by irreversible obstruction of the airways.